Cetera Investment Advisers’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Sell |
54,728
-3,452
| -6% | -$74.9K | ﹤0.01% | 2229 |
|
|
2025
Q1 | $1.41M | Buy |
58,180
+15,066
| +35% | +$365K | ﹤0.01% | 1996 |
|
|
2024
Q4 | $900K | Buy |
43,114
+11,221
| +35% | +$234K | ﹤0.01% | 2230 |
|
|
2024
Q3 | $634K | Sell |
31,893
-2,053
| -6% | -$40.8K | ﹤0.01% | 2461 |
|
|
2024
Q2 | $526K | Buy |
33,946
+5,197
| +18% | +$80.5K | ﹤0.01% | 2557 |
|
|
2024
Q1 | $458K | Buy |
28,749
+6,933
| +32% | +$111K | ﹤0.01% | 2669 |
|
|
2023
Q4 | $367K | Buy |
21,816
+6,533
| +43% | +$110K | ﹤0.01% | 1667 |
|
|
2023
Q3 | $179K | Buy |
15,283
+60
| +0.4% | +$701 | ﹤0.01% | 2002 |
|
|
2023
Q2 | $205K | Buy |
15,223
+1,096
| +8% | +$14.7K | ﹤0.01% | 1975 |
|
|
2023
Q1 | $234K | Buy |
14,127
+1,127
| +9% | +$18.7K | ﹤0.01% | 1854 |
|
|
2022
Q4 | $242K | Buy |
+13,000
| New | +$242K | ﹤0.01% | 1791 |
|
|
2022
Q3 | – | Sell |
-17,275
| Closed | -$121K | – | 1758 |
|
|
2022
Q2 | $121K | Hold |
17,275
| – | – | ﹤0.01% | 1724 |
|
|
2022
Q1 | $143K | Sell |
17,275
-377
| -2% | -$3.12K | ﹤0.01% | 1770 |
|
|
2021
Q4 | $120K | Hold |
17,652
| – | – | ﹤0.01% | 1780 |
|
|
2021
Q3 | $94K | Hold |
17,652
| – | – | ﹤0.01% | 1739 |
|
|
2021
Q2 | $101K | Buy |
17,652
+543
| +3% | +$3.11K | ﹤0.01% | 1722 |
|
|
2021
Q1 | $79K | Buy |
17,109
+109
| +0.6% | +$503 | ﹤0.01% | 1565 |
|
|
2020
Q4 | $57K | Buy |
+17,000
| New | +$57K | ﹤0.01% | 1539 |
|